Clinical Trial Update: Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gemcitabine plus paclitaxel versus gemcitabine alone after FOLFIRINOX failure in metastatic pancreatic adenocarcinoma has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2026-01-15